The FDA has approved nivolumab plus chemotherapy as a neoadjuvant treatment for operable stage IIA to IIIB non–small cell ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ...

Dividend investing can create substantial passive income over time. A conservative example illustrates this potential: ...

The Centers for Medicare & Medicaid Services (CMS) has added several changes to the Medicare price negotiation process ...

The US Food and Drug Administration (FDA) has approved a drug for schizophrenia that is exciting the field with an entirely ...

WARN notices filed with the state show more job cuts due in the health sector as companies look to cut costs and streamline ...

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...

By leveraging AI, drug developers are moving beyond incremental gains in efficiency and engaging previously undruggable ...

Exscientia detailed how its robotics lab in Oxfordshire, UK, is increasing productivity and efficiency in developing new ...

Two strategies to de-escalate treatment for human papillomavirus (HPV)-positive oropharyngeal cancer failed to show ...

Focus is turning to the development of peptide analogues of antibody-derived radiotherapeutics, according to Dr Dave Madge.